FJPCX
Price
$20.17
Change
-$0.13 (-0.64%)
Updated
Sep 12 closing price
Net Assets
839.74M
MIJFX
Price
$23.92
Change
-$0.12 (-0.50%)
Updated
Sep 12 closing price
Net Assets
690.75M
Interact to see
Advertisement

FJPCX vs MIJFX

Header iconFJPCX vs MIJFX Comparison
Open Charts FJPCX vs MIJFXBanner chart's image
Fidelity Advisor Japan C
Price$20.17
Change-$0.13 (-0.64%)
VolumeN/A
Net Assets839.74M
Matthews Japan Instl
Price$23.92
Change-$0.12 (-0.50%)
VolumeN/A
Net Assets690.75M
FJPCX vs MIJFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FJPCX vs. MIJFX commentary
Sep 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FJPCX is a Buy and MIJFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FJPCX has more cash in the bank: 840M vs. MIJFX (691M). MIJFX pays higher dividends than FJPCX: MIJFX (1.90) vs FJPCX (1.31). FJPCX was incepted earlier than MIJFX: FJPCX (15 years) vs MIJFX (15 years). FJPCX (1.70) is less costly to investors than MIJFX (1.08). MIJFX is a more actively managed with annual turnover of: 88.02 vs. FJPCX (21.00). FJPCX has a lower initial minimum investment than MIJFX: FJPCX (0) vs MIJFX (100000). FJPCX annual gain was more profitable for investors over the last year : 16.95 vs. MIJFX (15.54). FJPCX return over 5 years is better than : 23.29 vs. MIJFX (7.70).
FJPCXMIJFXFJPCX / MIJFX
Total Expense Ratio1.701.08157%
Annual Report Gross Expense Ratio1.701.08157%
Fund Existence15 years15 years-
Gain YTD26.29919.064138%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets840M691M122%
Annual Yield % from dividends1.311.9069%
Returns for 1 year16.9515.54109%
Returns for 3 years53.8560.7689%
Returns for 5 years23.297.70303%
Returns for 10 years88.4547.74185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XBIO3.600.50
+16.13%
Xenetic Biosciences
ENTG87.253.72
+4.45%
Entegris
INTT7.280.12
+1.68%
inTEST Corp
BALY9.92-0.08
-0.80%
Bally's Corporation
EFSC60.53-0.71
-1.16%
Enterprise Financial Services Corp